Skip to main content

Table 2 Comparison of clinical factors and visual acuity in children with residual amblyopia following occlusion for more than 6 months according to the treatment modalities

From: Effectiveness of binocularity-stimulating treatment in children with residual amblyopia following occlusion

 

BF (n = 10)

HMD (n = 7)

BF + HMD (n = 5)

P value

Sex (male:female)

6:4

5:2

4:1

0.852b

Types of amblyopia (A:S:C)

3:5:2

3:2:2

1:1:3

0.634b

VA at initial visit (LogMAR)

0.66 ± 0.44

0.77 ± 0.53

0.80 ± 0.58

0.844a

Duration of occlusion (years)

2.9 ± 1.3

2.6 ± 1.0

1.8 ± 0.5

0.215a

VA after occlusion (LogMAR)

0.17 ± 0.12

0.30 ± 0.32

0.21 ± 0.11

0.411a

Age at binocular treatment (years)

8.3 ± 1.2

8.7 ± 1.5

9.5 ± 1.4

0.289a

Duration of binocular treatment (months)

4.7 ± 2.4

4.2 ± 1.4

4.1 ± 1.1

0.795a

VA after binocular treatment (LogMAR)

0.19 ± 0.17

0.17 ± 0.07

0.17 ± 0.19

0.958a

  1. Continuous variables are reported as mean ± standard deviation
  2. Abbreviations: BF Bangerter foil, HMD Head-mounted display, A anisometropic, S strabismic, C combined, VA visual acuity, LogMAR logarithm of the minimum angle of resolution
  3. aANOVA test
  4. bFisher’s exact test